77 related articles for article (PubMed ID: 12173036)
21. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes.
Fu B; Quintero J; Baker CC
Cancer Res; 2003 Nov; 63(22):7815-24. PubMed ID: 14633708
[TBL] [Abstract][Full Text] [Related]
22. Modulation of transcriptional regulatory properties of p53 by HPV E6.
Crook T; Fisher C; Masterson PJ; Vousden KH
Oncogene; 1994 Apr; 9(4):1225-30. PubMed ID: 8134125
[TBL] [Abstract][Full Text] [Related]
23. Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.
Chien WM; Parker JN; Schmidt-Grimminger DC; Broker TR; Chow LT
Cell Growth Differ; 2000 Aug; 11(8):425-35. PubMed ID: 10965847
[TBL] [Abstract][Full Text] [Related]
24. G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells.
Yoshida J; Ishibashi T; Nishio M
Biochem Pharmacol; 2007 Apr; 73(7):943-53. PubMed ID: 17217918
[TBL] [Abstract][Full Text] [Related]
25. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
Malashicheva AB; Kisliakova TV; Pospelov VA
Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
[TBL] [Abstract][Full Text] [Related]
26. G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein.
Gonzales AJ; Fry DW
Exp Cell Res; 2005 Feb; 303(1):56-67. PubMed ID: 15572027
[TBL] [Abstract][Full Text] [Related]
27. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
28. HPV-18 transformed cells fail to arrest in G1 in response to quercetin treatment.
Beniston RG; Campo MS
Virus Res; 2005 May; 109(2):203-9. PubMed ID: 15763151
[TBL] [Abstract][Full Text] [Related]
29. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
Kaproth-Joslin KA; Li X; Reks SE; Kelley GG
Biochem J; 2008 Nov; 415(3):439-48. PubMed ID: 18588506
[TBL] [Abstract][Full Text] [Related]
30. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.
Mansour M; Touka M; Hasan U; Bellopede A; Smet A; Accardi R; Gabet AS; Sylla BS; Tommasino M
Virology; 2007 Oct; 367(1):1-9. PubMed ID: 17568647
[TBL] [Abstract][Full Text] [Related]
31. Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.
Fiaschi-Taesch N; Sicari BM; Ubriani K; Bigatel T; Takane KK; Cozar-Castellano I; Bisello A; Law B; Stewart AF
Circ Res; 2006 Oct; 99(9):933-42. PubMed ID: 17023675
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
33. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints.
Thompson DA; Belinsky G; Chang TH; Jones DL; Schlegel R; Münger K
Oncogene; 1997 Dec; 15(25):3025-35. PubMed ID: 9444951
[TBL] [Abstract][Full Text] [Related]
34. Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E.
Martin LG; Demers GW; Galloway DA
J Virol; 1998 Feb; 72(2):975-85. PubMed ID: 9444990
[TBL] [Abstract][Full Text] [Related]
35. Acute renal failure during sepsis: potential role of cell cycle regulation.
Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
[TBL] [Abstract][Full Text] [Related]
36. Interactions of the human papillomavirus E7 protein with cell cycle regulators.
Jones DL; Münger K
Semin Cancer Biol; 1996 Dec; 7(6):327-37. PubMed ID: 9284525
[TBL] [Abstract][Full Text] [Related]
37. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.
Murvai M; Borbély AA; Kónya J; Gergely L; Veress G
Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353
[TBL] [Abstract][Full Text] [Related]
38. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest.
Giarrè M; Caldeira S; Malanchi I; Ciccolini F; Leão MJ; Tommasino M
J Virol; 2001 May; 75(10):4705-12. PubMed ID: 11312342
[TBL] [Abstract][Full Text] [Related]
39. Alteration of cell cycle in cervical tumor associated with human papillomavirus: cyclin-dependent kinase inhibitors.
Cho NH; Kim YT; Kim JW
Yonsei Med J; 2002 Dec; 43(6):722-8. PubMed ID: 12497655
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of human papillomavirus type 16 E7 protein bypasses G1 arrest induced by serum deprivation and by the cell cycle inhibitor p21.
Morozov A; Shiyanov P; Barr E; Leiden JM; Raychaudhuri P
J Virol; 1997 May; 71(5):3451-7. PubMed ID: 9094616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
